Abstract

Patients with end stage renal disease (ESRD) are at high risk of developing upper tract urothelial carcinoma (UTUC). Due to high recurrence rate of UTUC in contralateral kidney and ureter, and high risk of complications related to surgery and anesthesia, whether it’s necessary to remove both kineys and ureters at one time remains in debate. We utilized Taiwanese UTUC Registry Database to valuate the difference of oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving surgical resection. Patients with ESRD and UTUC were divided into three groups, unilateral UTUC, previous history of unilateral UTUC with metachronous contralateral UTUC, and concurrent bilatetral UTUC. Oncological outcomes, perioperative complications, and length of hospital stays were investiaged. We found that there is no diffence of oncological outcomes including overall survival, cancer specific survival, disease free survival and bladder recurrence free survival between these three groups. Complication rate and length of hospital stay are similar. Adverse oncological features such as advanced tumor stage, lymph node involvement, lymphovascular invasion, and positive surgical margin would negatively affect oncological outcomes.

Details

Title
No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy
Author
Lin, Tsu-Chen 1 ; Chen, Guan-Heng 2 ; Yeh, Chin-Chung 3 ; Ke, Hung-Lung 4 ; Li, Wei-Ming 4 ; Tsai, Yao-Chou 5 ; Wu, Shu-Yu 5 ; Huang, Chao-Yuan 6 ; Chen, Chung-Hsin 6 ; Lin, Wun-Rong 7 ; Chen, Marcelo 7 ; Lo, Shih-Hsiu 8 ; Pang, See-Tong 9 ; Lin, Po-Hung 10   VIAFID ORCID Logo 

 Chang Gung Memorial Hospital, Linkou Branch, Division of Urology, Department of Surgery, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593) 
 China Medical University Hsinchu Hospital, Department of Urology, Hsinchu, Taiwan (GRID:grid.413801.f) 
 China Medical University Hospital, Department of Urology, Taichung, Taiwan (GRID:grid.411508.9) (ISNI:0000 0004 0572 9415) 
 Kaohsiung Medical University Hospital, Department of Urology, Kaohsiung, Taiwan (GRID:grid.412027.2) (ISNI:0000 0004 0620 9374) 
 Taipei Tzu Chi Hospital, Department of Urology, New Taipei, Taiwan (GRID:grid.481324.8) (ISNI:0000 0004 0404 6823) 
 National Taiwan University Hospital, Department of Urology, Taipei, Taiwan (GRID:grid.412094.a) (ISNI:0000 0004 0572 7815) 
 MacKay Memorial Hospital, Department of Urology, Taipei, Taiwan (GRID:grid.413593.9) (ISNI:0000 0004 0573 007X) 
 Taipei Medical University Hospital, Department of Urology, Taipei, Taiwan (GRID:grid.412897.1) (ISNI:0000 0004 0639 0994) 
 Chang Gung Memorial Hospital, Linkou Branch, Division of Urology, Department of Surgery, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593); Chang Gung University, School of Medicine, College of Medicine, Taoyuan, Taiwan (GRID:grid.145695.a) (ISNI:0000 0004 1798 0922) 
10  Chang Gung Memorial Hospital, Linkou Branch, Division of Urology, Department of Surgery, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593); Chang Gung University, School of Medicine, College of Medicine, Taoyuan, Taiwan (GRID:grid.145695.a) (ISNI:0000 0004 1798 0922); Chang Gung University, Graduate Institute of Clinical Medical Science, College of Medicine, Taoyuan, Taiwan (GRID:grid.145695.a) (ISNI:0000 0004 1798 0922) 
Pages
17766
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3087040565
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.